ArticleBMC bioinformatics2026
ACVI-Med, an open source variant interpretation tool for medical genomics.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- T-rex: standardized analysis of germline variants in whole-exome sequencing trios.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe adoption of whole genome and exome sequencing (WGS/WES) is expanding rapidly, yet variant interpretation remains a critical bottleneck, limiting diagnostic yield and delaying precision care. We present ACVI-Med (Accelerated Candidate Variant Interpretation in Medicine), an open-source, on-premise platform for comprehensive analysis of genomic data.
resultsACVI-Med integrates phenotype-aware filtering, ACMG-guided variant classification, and secondary findings detection into a unified, containerized system built for reproducibility and deployment across diverse institutional environments. Designed for accessibility, ACVI-Med enables users without extensive bioinformatics expertise to interpret variants from VCF (Variant Call Format) files through a flexible interface supporting phenotype-driven filtering, ACMG-guided variant classification, and integration of population, clinical, and predictive annotations. The software incorporates modules for secondary findings detection, aligned with ACMG Secondary Findings v3.2 recommendations, extending its utility beyond primary variant analysis. ACVI-Med’s customizable filtering logic, real-time access to curated knowledge bases, and interactive visualization tools support transparent and reproducible genomic interpretation.
conclusionACVI-Med is an open-source software for genomic variant interpretation. Unlike commercial solutions, ACVI-Med is cost-effective, containerized, and can be institutionally self-hosted, reducing barriers to adoption in research settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.